Signaling pathways involved in colorectal cancer progression
Zahra Koveitypour, Farnoush Panahi, Mehrdad Vakilian et al. · Cell & Bioscience · 2019 · Review
Full textCC BY
Oncology
Filters3 filters applied
Year
Readable here
Study type
Licence
Xenograft and organoid model systems in cancer research
Margit Bleijs, Marc van de Wetering, Hans Clevers et al. · The EMBO Journal · 2019 · Review
Full textCC BY
Clinical development of targeted and immune based anti-cancer therapies
N. A. Seebacher, A. E. Stacy, G. M. Porter et al. · Journal of Experimental & Clinical Cancer Research · 2019 · Review
Full textCC BY
Resilience in Cancer Patients
Annina Seiler, Josef Jenewein · Frontiers in Psychiatry · 2019 · Review
Full textCC BY
Engineered T Cell Therapy for Cancer in the Clinic
Lijun Zhao, Yu J. Cao · Frontiers in Immunology · 2019 · Review
Full textCC BY
Chemoresistance in Pancreatic Cancer
Siyuan Zeng, Marina Pöttler, Bin Lan et al. · International Journal of Molecular Sciences · 2019 · Review
Full textCC BY
Delivery strategies of cancer immunotherapy: recent advances and future perspectives
Zhongwei Zhao, Liyun Zheng, Weiqian Chen et al. · Journal of Hematology & Oncology · 2019 · Review
Full textCC BY
Mechanisms of Relapse After CD19 CAR T-Cell Therapy for Acute Lymphoblastic Leukemia and Its Prevention and Treatment Strategies
Xinjie Xu, Qihang Sun, Xiaoqian Liang et al. · Frontiers in Immunology · 2019 · Review
Full textCC BY
Immune checkpoint inhibitors of PD-L1 as cancer therapeutics
Akintunde Akinleye, Zoaib Rasool · Journal of Hematology & Oncology · 2019 · Review
Full textCC BY
Roles of GM-CSF in the Pathogenesis of Autoimmune Diseases: An Update
Noushin Lotfi, Rodolfo Thome, Nahid Rezaei et al. · Frontiers in Immunology · 2019 · Review
Full textCC BY
Role of the dynamic tumor microenvironment in controversies regarding immune checkpoint inhibitors for the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations
Anqi Lin, Ting Wei, Hui Meng et al. · Molecular Cancer · 2019 · Review
Full textCC BY
Clusterin in Alzheimer’s Disease: Mechanisms, Genetics, and Lessons From Other Pathologies
Evangeline M. Foster, Adrià Dangla-Valls, Simon Lovestone et al. · Frontiers in Neuroscience · 2019 · Review
Full textCC BY
Gain-of-Function Mutant p53: All the Roads Lead to Tumorigenesis
Yan Stein, Varda Rotter, Ronit Aloni-Grinstein · International Journal of Molecular Sciences · 2019 · Review
Full textCC BY
The Intriguing History of Cancer Immunotherapy
Paula Dobosz, Tomasz Dzieciątkowski · Frontiers in Immunology · 2019 · Review
Full textCC BY
Monalizumab: inhibiting the novel immune checkpoint NKG2A
Thorbald van Hall, Pascale André, Amir Horowitz et al. · Journal for ImmunoTherapy of Cancer · 2019 · Review
Full textCC BY
Inflammation and Lymphatic Function
Simon Schwager, Michael Detmar · Frontiers in Immunology · 2019 · Review
Full textCC BY
STAT3, a Master Regulator of Anti-Tumor Immune Response
Cédric Rébé, François Ghiringhelli · Cancers · 2019 · Review
Full textCC BY
Lymph Node Subcapsular Sinus Macrophages as the Frontline of Lymphatic Immune Defense
Dante Alexander Patrick Louie, Shan Liao · Frontiers in Immunology · 2019 · Review
Full textCC BY
Drug resistance and combating drug resistance in cancer
Xuan Wang, Haiyun Zhang, Xiaozhuo Chen · Cancer Drug Resistance · 2019 · Review
Full textCC BY
CAR T Cells for Solid Tumors: New Strategies for Finding, Infiltrating, and Surviving in the Tumor Microenvironment
Marina Martinez, Edmund Kyung Moon · Frontiers in Immunology · 2019 · Review
Full textCC BY